Lisa Spees, PhD, is currently an Assistant Professor in the Division of Pharmaceutical Outcomes and Policy at the University of North Carolina at Chapel Hill in the Eshelman School of Pharmacy. At Lineberger Comprehensive Cancer Center (LCCC), she is the Director of Cancer Health Assets and Needs Assessment (CHANA) in the Office of Community Outreach and Engagement, an Associate Member of the Cancer Prevention and Control Program, and a member of the Culture, Climate, and Training Committee within the Lineberger Equity Council.

Cohort and Case-Control Studies, Data Linkage, Health Economics, Quantitative Research, Randomized Control Trials, Comparative Effectiveness, Health Disparities, Health Outcomes, Health Policy, Health Services, Intervention Research, Mental Health, Pediatrics, Pharmaceutical Policy, Rural Health

Clinical Registries, Drug Utilization Research, Health Economics, Systematic Reviews and Meta-Analyses, Adverse Drug Reactions, Clinical Education, Drug Safety, Educational Research, Medication Safety, Opioids, Pharmacoepidemiology, Pharmacy Practice, Post-marketing surveillance, Toxicology

Drug Utilization Research, Health Economics, Mathematical Modelling, Quantitative Research, Systematic Reviews and Meta-Analyses, Antibiotics, Bacterial resistance, Global Health, Health Outcomes, Health Policy, Infectious Diseases, Medication Safety, Pharmacoeconomics, Population Health, Vaccines

Artificial Intelligence, Drug Utilization Research, Health Economics, Machine Learning, Quantitative Research Adherence/Persistence, Health Outcomes, Health Policy, Implementation Science, Machine Learning, Medication Adherence, Medication Optimization, Opioids, Pharmaceutical Policy, Pharmaceutical Services, Pharmacy Practice, Population Health

Biobanks, Clinical Registries, Health Economics, Systematic Reviews and Meta-Analyses, Cancer, Immunotherapy, Oncology, Palliative care, Pharmacogenetics, Pharmacogenomics, Pharmacy Practice, Precision Dosing, Precision Medicine, Tumor Microenvironment